| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cormedix Inc. (CRMD) has 10 insiders with recent SEC Form 4 filings, including 6 buys and 10 sells. CRMD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 774.7K | $6.83M | - | |
| COO | 278.5K | $2.46M | - | |
| Other | 269.1K | $2.37M | - | |
| Dir | 201.0K | $1.77M | - | |
| Other | 133.2K | $1.17M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 9, 2016 | Baluch Khoso | Chief Executive Officer | Buy | 10,000 | $1.77 | $17,700.00 | New | |
| Nov 30, 2016 | Tellez Cora M | Director | Buy | 1,800 | $1.80 | $3,240.00 | +1.6% | |
| Oct 31, 2016 | Tellez Cora M | Director | Buy | 1,475 | $2.15 | $3,171.25 | +1.3% | |
| Oct 21, 2016 | Pfaffle Antony | Chief Scientific Officer | Sale+OE | 20,000 | $2.23 | $44,600.00 | -100% | |
| Aug 25, 2016 | Markvicka Taunia | Director | Buy | 18,600 | $1.65 | $30,690.00 | +465.0% | |
| Aug 19, 2016 | Tellez Cora M | Director | Buy | 12,500 | $1.73 | $21,587.50 | +12.9% | |
| Aug 19, 2016 | Kaplan Myron | Director | Buy | 20,000 | $1.72 | $34,496.00 | New | |
| Jun 21, 2016 | Pfaffle Antony | Interim Chief Medical Officer | Sale+OE | 29,657 | $2.14 | $63,340.11 | -61.4% | |
| Jun 15, 2016 | Pfaffle Antony | Interim Chief Medical Officer | Sale+OE | 4,900 | $2.21 | $10,817.73 | -100% | |
| Jun 13, 2016 | Pfaffle Antony | Interim Chief Medical Officer | Sale+OE | 5,443 | $2.27 | $12,380.60 | -100% |